Scientists hunt for genetic clues to personalize diabetes treatment
NCT ID NCT02891954
Summary
This study aims to understand if a person's genes can predict how they will respond to a common diabetes drug called canagliflozin. Researchers are giving the drug to 700 healthy Amish volunteers and measuring its effects on the body. They will then look for genetic patterns linked to these effects, which could one day help doctors choose the right medication for each patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.